Hunter Perkins Capital Management, LLC Moderna, Inc. Transaction History

Hunter Perkins Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$126.46 - $235.05 $120,137 - $223,297	-950 Closed	0 $0
Q4 2021 Jan 27, 2022	SELL	$225.82 - $368.51 $90,328 - $147,404	-400 Reduced 29.63%	950 $241,000
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $33,285 - $72,670	-150 Reduced 10.0%	1,350 $520,000
Q2 2021 Jul 30, 2021	SELL	$129.91 - $234.98 $38,973 - $70,494	-300 Reduced 16.67%	1,500 $352,000
Q1 2021 Apr 28, 2021	SELL	$109.18 - $185.98 $21,836 - $37,196	-200 Reduced 10.0%	1,800 $236,000
Q4 2020 Feb 03, 2021	BUY	$65.74 - $169.86 $131,480 - $339,720	2,000 New	2,000 $209,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Hunter Perkins Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hunter Perkins Capital Management, LLC with notifications on news.